Dr. Phillip Frost stated, "We make this investment with enthusiasm. Alliqua has made considerable progress on the development of its PHN patch, which addresses a large and growing market. Additionally, we are impressed with the development of several other products and its IP portfolio, which has considerable market potential."
Alliqua's Chairman, David Stefansky, stated, "We are very excited to have Dr. Frost as an investor in Alliqua in light of his past accomplishments, as it demonstrates a great endorsement of our future success by one of the world's leading investors. Moreover, given Dr. Frost's knowledge and experience in the bio-medical industry, we believe that Dr. Frost's involvement in the company will be invaluable in helping us maximize shareholder value."
Matt Harriton, the CEO of Alliqua BioMedical, Inc., a wholly owned subsidiary of Alliqua, further stated, "Dr. Frost's investment is an extremely exciting affirmation of our business plan and products, especially in a field in which he has tremendous proven knowledge."
This note is OLD NEWS as the investment was announced months ago. Perhaps you are not aware of this or perhaps you are just trying to "pump up" the price. In any case, I again suggest that an investor read the most recent 10K filing. It seems to indicate that this company is seemingly run for the benefit of insiders at this point in time in terms of perks, rents paid to themselves or the entities that they seem to control. This seems to be evidenced by large SG&A expenses with VERY LITTLE R&D as far as I can tell. I had asked the board the question if anyone could buy the entire company (which was worth 30+ million dollars when I first posed the question and now is worth about 20 million dollars) if a person would pay this amount of money for a company that seems to not be worth a whole lot. Oh, I forgot, they have almost 1 penny per share in cash. My thoughts and opinion only FYI. Looking forward to ANY INFORMATION that might change my opinion.